CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.74B, above the global median of $1.18B
- FinancialsLow earnings quality
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.23%
Annual Rate
CNY 0.06Paid unknown
Payout Ratio
26.7%Sustainable
Last Ex-Dividend
May 14, 2026
The reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
11.65BCNY1.74B · vs all stocks (USD)
Trailing P/E
113.73xRevenue (TTM)
1.05BCNY156.24M · vs all stocks (USD)
Profit Margin
8.86%Beta
0.6400xvs all stocks
52-Week Change
-20.66%vs all stocks
Forward Annual Dividend Yield
0.23%vs all stocks
Market Capitalization
11.65BCNY1.74B · vs all stocks (USD)
Enterprise Value
11.03BCNY1.65B · vs all stocks (USD)
Trailing P/E
113.73xForward P/E
-125.10xPrice to Sales (TTM)
10.59xPrice to Book (MRQ)
4.34xEnterprise to Revenue
10.54xEnterprise to EBITDA
53.06xGross Margin
86.81%Profit Margin
8.86%Operating Margin
20.35%Return on Assets (TTM)
2.13%Return on Equity (TTM)
4.45%Revenue (TTM)
1.05BCNY156.24M · vs all stocks (USD)
Revenue per Share (TTM)
2.49CNYUpdated Sep 22, 2026Quarterly Revenue Growth
17.10%Gross Profit (TTM)
908.96MCNY135.68M · vs all stocks (USD)
EBITDA (TTM)
158.74MCNY23.69M · vs all stocks (USD)
Net Income (TTM)
92.75MCNY13.84M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-11.60%Operating Cash Flow (TTM)
124.27MCNY18.55M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
297.92MCNY44.47M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0600CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
0.23%vs all stocks
Trailing Annual Dividend Rate
0.0580CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.24%vs all stocks
Payout Ratio
26.74%Revenue
910.06MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
117.23MCNYFY2025 · Dec 31, 2025Gross Profit
792.83MCNYFY2025 · Dec 31, 2025Operating Income
99.64MCNY14.87M · vs all stocks (USD)
Pre-tax Income
50.05MCNYFY2025 · Dec 31, 2025Income Tax Expense
-906.71KCNYFY2025 · Dec 31, 2025Net Income
50.96MCNYFY2025 · Dec 31, 2025EBIT
85.75MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
158.74MCNYFY2025 · Dec 31, 2025Research & Development
221.62MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
262.28MCNYFY2025 · Dec 31, 2025Other Operating Expenses
16.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
17.04MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
35.70MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
50.96MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-101.84MCNYFY2025 · Dec 31, 2025Free Cash Flow
-280.43MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
228.68MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
50.96MCNYFY2025 · Dec 31, 2025Other Non-cash Items
25.63MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-160.14MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.29MCNYFY2025 · Dec 31, 2025Capital Expenditures
-178.59MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.71BCNYFY2025 · Dec 31, 2025Sale of Investments
1.67BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-217.62MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
491.90MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-310.94MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-31.74MCNYFY2025 · Dec 31, 2025Other Financing Charges
-21.62MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
127.60MCNYFY2025 · Dec 31, 2025Shares Outstanding
442.94MSharesUpdated Sep 22, 2026Float Shares
315.11MSharesUpdated Sep 22, 2026% Held by Insiders
25.39%vs all stocks
% Held by Institutions
4.14%vs all stocks
Total Cash (MRQ)
1.54BCNY229.23M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.47CNYUpdated Sep 22, 2026Total Debt (MRQ)
1.51BCNY224.82M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5906xCurrent Ratio (MRQ)
2.38xBook Value per Share (MRQ)
5.77CNYUpdated Sep 22, 2026Total Assets
3.65BCNY544.91M · vs all stocks (USD)
Total Current Assets
1.18BCNYFY2025 · Dec 31, 2025Total Liabilities
2.02BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.47BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.18BCNYFY2025 · Dec 31, 2025Total Current Liabilities
843.90MCNYFY2025 · Dec 31, 2025Cash
347.57MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.33KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
347.57MCNYFY2025 · Dec 31, 2025Other Short-term Investments
295.30MCNYFY2025 · Dec 31, 2025Accounts Receivable
286.99MCNYFY2025 · Dec 31, 2025Inventory
57.68MCNYFY2025 · Dec 31, 2025Accounts Payable
3.78MCNYFY2025 · Dec 31, 2025Short-term Debt
507.44MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.55MCNYFY2025 · Dec 31, 2025Long-term Debt
1.04BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
162.88KCNYFY2025 · Dec 31, 2025Common Stock (Book)
407.81MCNYFY2025 · Dec 31, 2025Retained Earnings
45.76MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.63BCNY242.69M · vs all stocks (USD)
Treasury Stock
15.00MCNYFY2025 · Dec 31, 202552-Week Low
23.41CNYUpdated Sep 22, 202652-Week High
36.47CNYUpdated Sep 22, 202652-Week Change
-20.66%vs all stocks
Beta
0.6400xvs all stocks
50-Day MA
27.33CNYUpdated Sep 22, 2026200-Day MA
29.21CNYUpdated Sep 22, 2026Avg 10-Day Volume
5.94MSharesUpdated Sep 22, 2026Avg 30-Day Volume
11.26MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.2200CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.17Receivables vs revenue divergence: 3.55
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -1.33
Altman Z-Score 3.91: safe zoneNotable
Altman Z-Score: 3.91
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.74B, above the global median of $1.18BNotable
Market cap (USD): 1,739,561,920.091Global Median: 1,180,223,658.953
Levered free cash flow is $44.47M, above the global median of $18.73MNotable
Levered free cash flow (USD): 44,470,112.386Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Hanall Biopharma Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanobiotix S.A.
Tier 1ProductionApproval-Gated PipelineRule
Inventisbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Jubilant Pharmova Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alembic Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Novavax Inc.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Aosaikang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangxi Fushine Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Septarna Inc.
Tier 1ProductionApproval-Gated PipelineRule
4DMedical Limited
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking